A comprehensive view of Injectables/Infusions/IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer announces US$750.0M expansion at Kalamazoo, Michigan, pharma plant to increase manufacturing capacity of sterile injectable medications; expansion could lead to 300 new jobs at plant that current has about 3,000 employees
Published: December 05, 2022 by Associated Press
Canada to buy 15,000 treatment courses of Roche’s Actemra IV tocilizumab injectable to treat adult patients hospitalized with COVID-19; an estimated 429 out of 1,000 patients hospitalized with COVID-19 are eligible for tocilizumab
Published: December 02, 2022 by Canada Newswire
FDA withdraws emergency use authorization of Eli Lilly’s bebtelovimab injectable COVID-19 antibody therapy, citing the therapy is most likely ineffective against Omicron BQ.1 and BQ.1.1; Lilly had supplied 60,000 doses of the drug to US government in Q3
Published: December 01, 2022 by SeeNews Pharmaceuticals
Roche receives Canadian approval for injectable Polivy polatuzumab vedotin to treat B-cell lymphoma; drug used in combination with Rituxan rituximab, cyclophosphamide, doxorubicin and immunosuppressive drug prednisone
Published: November 28, 2022 by SeeNews Pharmaceuticals
FDA approves Dutch biotech firm UniQure’s Hemgenix injectable to treat hemophilia B, making it the first gene therapy treatment for the disorder; Australian drugmaker CSL has license for the treatment and places list price at US$3.5M
Published: November 23, 2022 by BioPharma Dive

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count